1 November 2008 in Journal of Obstetric, Gynecologic, & Neonatal Nursing
1 May 2014 in Journal of Obstetric, Gynecologic, & Neonatal Nursing
1 October 2008 in AJN, American Journal of Nursing
Poor, urban, and immigrant populations are at far greater risk for lead exposure than are other groups in the United States. Children with even slightly elevated blood lead levels are at increased risk for significant neurobehavioral problems that can extend through adolescence. Research has shown that elevated blood lead levels in pregnant women, even those well below 10 micrograms per deciliter-the Centers for Disease Control and Prevention's "level of concern"-can cause miscarriage, premature birth, low birth weight, and subsequent developmental delays in their children. Despite these well-established dangers, routine prenatal lead screening and lead education is not a standard of care. Part 1 of this two-part article presents a short case example of a pregnant mother with lead poisoning and describes the epidemiology of lead exposure in the United States, the main sources of lead exposure, and the effects of lead on the pregnant mother and the developing fetus and child. Prevention is crucial. Treatment options such as chelation must be used selectively and will not reverse damage once it's occurred. Part 2 will describe recommendations for screening, education, nutrition, reducing environmental exposures, and treatment.
1 July 2013 in MCN: The American Journal of Maternal/Child Nursing
To describe the hospital experiences of mothers who give birth to substance-exposed infants. Secondary analysis of data from a larger study that was focused on the experiences of Mexican-American mothers in the neonatal intensive care unit (NICU) was conducted. Semistructured interviews with five women who were recovering addicts on methadone were analyzed. Each of their infants spent time in an NICU following birth. The transcribed interviews were analyzed using qualitative content analysis. Four themes were identified: (a) "try not to judge," (b) "scoring" the baby, (c) "share with me," and (d) "I'm the mother here!" The quality of the relationship between the mothers and the nurses in the NICU was a crucial aspect of the mothers' experiences and may have an effect on long-term outcomes. Women with addictions often have other significant risk factors that may further jeopardize their ability to mother; therefore, it is essential to develop a strong support network. Nurses can be instrumental in organizing resources for this population of women. Judging behaviors may have a detrimental effect on women with addictions. Maternal adaptation to the mothering role can be enhanced by making reasonable efforts to include the mother in the care of the infant.
12 April 2020 in Addiction
Background and Aims: Between 2007 and 2016, pregnancy‐associated mortality resulting from overdose more than doubled in the United States. This study explored the circumstances surrounding maternal opioid‐related morbidity and mortality, using the life‐course theory as a sensitizing framework to examine how each participant's life‐course contributed to her substance use, relapse, recovery or overdose.Design: A mixed‐methods study using semi‐structured, in‐depth face‐to‐face interviews and focus groups were conducted.Setting: Texas, United States.Participants: Women who had relapsed into opioid use or experienced a ‘near‐miss’ overdose and family members of women who had died during the maternal period due to opioid overdose were interviewed (n = 99).Measurements: A socio‐demographic questionnaire captured participants’ ethnicity, age, marital status, medical and mental health history and employment status. The Stressful Life Events Screening Questionnaire—revised (SLESQ‐R) assessed life‐time exposure to trauma.Findings: Women reported histories of abuse and loss of a loved one through homicide or suicide. Participants indicated that limited social support, interpersonal conflict with their partner and unaddressed mental illness made recovery more challenging. Additionally, losing their children through the child welfare system was described as punitive and placed them at greater risk for relapse and overdose.Conclusions: A life‐course theory approach to examining maternal opioid‐related morbidity and mortality in Texas, United States reveals the complex needs of women at risk for opioid use relapse and overdose and the significant role of previous traumatic experiences.
1 October 2020 in Advances in Neonatal Care
Background: The current US opioid crisis has resulted in a significant increase in opioid use disorder among pregnant and parenting women. Substance use disorders, in general, are highly stigmatized conditions. Stigma serves as a well-documented global barrier to health-seeking behaviors and engagement in healthcare. While extensive research exists on the stigma of mental illness, few studies have explored the stigma experienced by families impacted by neonatal abstinence syndrome (NAS). Purpose: Therefore, the purpose of this article is to explore the role of stigma in the care of families impacted by NAS. Methods: In this article, we present a discussion about the effects of stigma on this patient population and provide exemplars of stigma experiences from our previous research and the existing literature. Findings/Results: Mothers of infants with NAS faced the challenges of overcoming stigma as they were often ostracized, excluded, and shamed. Nurses who provide care for these women and their infants have reported experiencing ethical distress, moral distress, and compassion fatigue. Implications for Practice: Greater awareness of the impact of opioid use on the maternal–child population has resulted in numerous educational offerings for healthcare providers; however, this alone is not adequate to end stigma. Fortunately, promising tools and methods have been developed for assisting nurses with addressing stigma in a manner that can be both nonconfrontational and highly effective. Implications for Research: Future research is needed to explore and evaluate the efficacy of various existing strategies for counteracting harmful stigma in this patient population.